跳至主要内容
临床试验/NL-OMON55680
NL-OMON55680尚未招募不适用

The effect of a gastric bypass on the pharmacokinetics of citalopram - CITA II

Maasstadziekenhuis0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age of 18 years and older
  • - The patient uses citalopram daily
  • - The patient is prescribed citalopram at least 2 month before included in the
  • studie, and uses the same dose for at least one week before bloodsampling
  • - The patient is on the waitinglist for a primairy Roux- and Y gastric bypass
  • - The patient is a patient in the Maasstad ziekenhuis or the Franciscus
  • Gasthuis en Vlietland
  • - The patient participates voluntary in the study
  • - The patient has read and understands the information letter and has signed
  • the consent form

排除标准

  • - Persons who have previously undergone a bariatric procedure
  • - Persons with an impaired liver and/or kidney function (ALAT> 80 U / l; gamma
  • GT> 100 U / L; MDRD <50 ml / min)
  • - Women who are pregnant or are breastfeeding
  • - Patients who are incompetent
  • - The participant is on the waiting list for a mini bypass, gastric band,
  • gastric sleeve or biliopancreatic diversion

研究者

发起方
Maasstadziekenhuis

相似试验